Bernard A. Fox

17.9k citations

200 papers · 7.6k indexed · 3 hit papers · h-index 48

Impact in

Immunology top 0.2%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immune cells in cancer
Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research

Papers in

Immunology 145
- Immunotherapy and Immune Responses 122
- Immune Cell Function and Interaction 40
- T-cell and B-cell Immunology 25
Oncology 137
- Cancer Immunotherapy and Biomarkers 87
- CAR-T cell therapy research 67

Co-authors: Walter J. Urba Hong‐Ming Hu Shawn M. Jensen Alfred E. Chang Gary J. Nabel Rom S. Leidner S Shu Gregory E. Plautz
Journals: Journal for ImmunoTherapy of Cancer (29 papers)The Journal of Immunology (15 papers)Journal of Clinical Oncology (13 papers)Journal of Translational Medicine (12 papers)Clinical Cancer Research (11 papers)
Partner nations: United States Germany France

In The Last Decade

Bernard A. Fox

195 papers receiving 7.4k citations

Hit Papers

align trajectories log scale

Neoantigen T-Cell Receptor Gene Therapy in Pancreatic Cancer 2022 · 319 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2022 New England Journal of Medicine
2018 Nature Communications
1993 Proceedings of the National Academy of Sciences

Peers

Countries citing papers authored by Bernard A. Fox

Since Specialization

Citations

This map shows the geographic impact of Bernard A. Fox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernard A. Fox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernard A. Fox more than expected).

Fields of papers citing papers by Bernard A. Fox

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernard A. Fox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernard A. Fox. The network helps show where Bernard A. Fox may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Bernard A. Fox, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Bernard A. Fox Line = papers co-authored together Bernard A. Fox links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Perspectives on the role of “-Omics” in predicting response to immunotherapy European Journal of Cancer ·Paul A. Ulrich, Sumit K. Subudhi, Wim Vos, Massimo Andreatta, Santiago J. Carmona, Qianyang Li, Barbara Seliger, Ramy Ibrahim, Rania Boudefla, Michael A. Smith, Alexander M.M. Eggermont, Bernard A. Fox, Michele Maio	2025	2
2	Immune cell topography of head and neck cancer Journal for ImmunoTherapy of Cancer ·James P. Boussy, Deepak Mawar, Shao-jie LIU, Barletta Claudia, Carmen Ballesteros‐Merino, Laura A. N. Peferoen, Elisabeth Bloemena, Bernard A. Fox, Jos B. Poell, C. René Leemans, Ruud H. Brakenhoff, Rieneke van de Ven	2024	5
3	149 Simultaneous identification of KRAS mutation-carrying multiple neoepitopes by differential ion mobility-assisted targeted-mass spectrometry SHILAP Revista de lepidopterología ·Yuriko Minegishi, Noriko Iwamoto, Takashi Shimada, Kazuma Kiyotani, Satoshi Nagayama, Eric Tran, Yoshinobu Koguchi, William L. Redmond, Brian Piening, Bernard A. Fox, Koji Ueda	2023	1
4	A rapid and universal liquid chromatograph-mass spectrometry-based platform, refmAb-Q nSMOL, for monitoring monoclonal antibody therapeutics The Analyst ·Noriko Iwamoto, Yoshinobu Koguchi, 马天璇, Akinobu Hamada, Atsushi Yonezawa, Brian Piening, Eric Tran, Bernard A. Fox, William L. Redmond, Takashi Shimada	2022	4
5	Robust Antitumor Immunity in a Patient with Metastatic Colorectal Cancer Treated with Cytotoxic Regimens Cancer Immunology Research ·Venkatesh Rajamanickam, Carmen Ballesteros‐Merino, E Barimboin, David Ross, Brady Bernard, Bernard A. Fox, Eric Tran, Pippa Newell, Thomas Duhen	2021	7
6	SARS-CoV-2 Antibodies Detected in Mother’s Milk Post-Vaccination Journal of Human Lactation ·James L. Newell, Shawn M. Jensen, Walter J. Urba, Bernard A. Fox, Jason R. Baird	2021	49
7	Perspectives in immunotherapy: meeting report from the immunotherapy bridge (December 2nd–3rd, 2020, Italy) Journal of Translational Medicine ·Paolo A. Ascierto, Carlo Bifulco, Fortunato Ciardiello, Sandra Demaria, Leisha A. Emens, Robert L. Ferris, Silvia C. Formenti, Jérôme Galon, Samir N. Khleif, Tomas Kirchhoff, Jennifer L. McQuade, Kunle Odunsi, Akash Patnaik, Chrystal M. Paulos, Janis M. Taube, John M. Timmerman, Bernard A. Fox, Patrick Hwu, Igor Puzanov	2021	3
8	Neoadjuvant anti-OX40 (MEDI6469) therapy in patients with head and neck squamous cell carcinoma activates and expands antigen-specific tumor-infiltrating T cells Nature Communications ·Rebekka Duhen, Carmen Ballesteros‐Merino, Alexandra K. Frye, Eric Tran, Venkatesh Rajamanickam, Shu‐Ching Chang, Yoshinobu Koguchi, Carlo Bifulco, Brady Bernard, Rom S. Leidner, Brendan D. Curti, Bernard A. Fox, Walter J. Urba, R. Bryan Bell, Andrew D. Weinberg	2021	114
9	No time to die: the consensus immunoscore for predicting survival and response to chemotherapy of locally advanced colon cancer patients in a multicenter international study OncoImmunology ·Paolo A. Ascierto, Francesco M. Marincola, Bernard A. Fox, Jérôme Galon	2020	11
10	Cumulative suppressive index as a predictor of relapse free survival and overall survival in Human Papilloma Virus‐negative oral squamous cell carcinomas with negative resection margins Head & Neck ·Arash Karimi Pour, Daniel Bethmann, Zipei Feng, Shu‐Ching Chang, Alexander Eckert, Carmen Ballesteros‐Merino, Tornio KAWATA, Matthias Kappler, Carlo Bifulco, Claudia Wickenhauser, Barbara Seliger, Bernard A. Fox, R. Bryan Bell	2020	6
11	The Society for Immunotherapy of Cancer perspective on regulation of interleukin-6 signaling in COVID-19-related systemic inflammatory response Journal for ImmunoTherapy of Cancer ·Fernanda I. Arnaldez, Steven O’Day, Charles G. Drake, Bernard A. Fox, M. Smith, Walter J. Urba, Vincenzo Montesarchio, Jeffrey S. Weber, Haiming Wei, Jon M. Wigginton, Paolo A. Ascierto	2020	68
12	Phase I Trial of an ICAM-1-Targeted Immunotherapeutic-Coxsackievirus A21 (CVA21) as an Oncolytic Agent Against Non Muscle-Invasive Bladder Cancer Clinical Cancer Research ·Nicola Annels, David Mansfield, 조행래, Carmen Ballesteros‐Merino, Guy R. Simpson, R. U. Gooding, JULIA CAIRA, Alan Melcher, Kevin J. Harrington, B. Švárová, Gough G. Au, Mark Grose, Izhar Bagwan, Bernard A. Fox, Richard G. Vile, Hugh Mostafid, Darren R. Shafren, Hardev Pandha	2019	97
13	The Epigenomic Landscape of Pituitary Adenomas Reveals Specific Alterations and Differentiates Among Acromegaly, Cushing's Disease and Endocrine-Inactive Subtypes Clinical Cancer Research ·Matthew P. Salomon, Xiaowen Wang, Diego M. Marzese, Sandy Hsu, Nellie Nelson, Xin Zhang, Chikako Matsuba, Y. K. Cho, Carmen Ballesteros‐Merino, Bernard A. Fox, Garni Barkhoudarian, Daniel F. Kelly, Dave S.�B. Hoon	2018	90
14	Timing of PD-1 Blockade Is Critical to Effective Combination Immunotherapy with Anti-OX40 Clinical Cancer Research ·David J. Messenheimer, Shawn M. Jensen, Michael Afentoulis, Keith W. Wegmann, Zipei Feng, David J. Friedman, Michael J. Gough, Walter J. Urba, Bernard A. Fox	2017	234
15	Heterodimeric IL15 Treatment Enhances Tumor Infiltration, Persistence, and Effector Functions of Adoptively Transferred Tumor-specific T Cells in the Absence of Lymphodepletion Clinical Cancer Research ·Sinnie Sin Man Ng, Sahar Abdulaziz, Shawn M. Jensen, Xintao Hu, Candido Alicea, Bernard A. Fox, Barbara K. Felber, Cristina Bergamaschi, George N. Pavlakis	2016	31
16	Sustained Complete Response to CTLA-4 Blockade in a Patient with Metastatic, Castration-Resistant Prostate Cancer Cancer Immunology Research ·Julie N. Graff, Sachin Puri, Carlo Bifulco, Bernard A. Fox, Tomasz M. Beer	2014	29
17	Tumor-Derived Autophagosome Vaccine: Induction of Cross-Protective Immune Responses against Short-lived Proteins through a p62-Dependent Mechanism Clinical Cancer Research ·Chris Twitty, Shawn M. Jensen, Hong‐Ming Hu, Bernard A. Fox	2011	78
18	Tumor-Derived Autophagosome Vaccine: Mechanism of Cross-Presentation and Therapeutic Efficacy Clinical Cancer Research ·Yuhuan Li, Lixin Wang, Puiyi Pang, Zhi-Hua Cui, Sandra Aung, Daniel Haley, Bernard A. Fox, Walter J. Urba, Hong‐Ming Hu	2011	115
19	Partial CD4 Depletion Reduces Regulatory T Cells Induced by Multiple Vaccinations and Restores Therapeutic Efficacy Clinical Cancer Research ·G. A. Jeiranian, Shawn M. Jensen, Bernard A. Fox	2009	33
20	Phenotype and Functional Characterization of Long-term gp100-Specific Memory CD8+ T Cells in Disease-Free Melanoma Patients Before and After Boosting Immunization Clinical Cancer Research ·Edwin Walker, Daniel Haley, Ulf Petrausch, Kevin Floyd, William L. Miller, Nixon Mc, E. V. RAMANOVA, Bernard A. Fox, Walter J. Urba	2008	24

About Bernard A. Fox

Bernard A. Fox is a scholar working on Immunology, Oncology, Biotechnology, Otorhinolaryngology and Radiology, Nuclear Medicine and Imaging, having authored 200 papers that have together received 7.6k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (122 papers), Cancer Immunotherapy and Biomarkers (87 papers), CAR-T cell therapy research (67 papers), Immune Cell Function and Interaction (40 papers), T-cell and B-cell Immunology (25 papers), Cancer Research and Treatments (17 papers), Virus-based gene therapy research (15 papers) and RNA Interference and Gene Delivery (13 papers). The work is most often cited by research in Immunology (4.4k citations), Oncology (4.4k citations), Biotechnology (336 citations), Genetics (954 citations) and Cancer Research (501 citations). Bernard A. Fox has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Walter J. Urba, Hong‐Ming Hu, Shawn M. Jensen, Alfred E. Chang, Gary J. Nabel, Rom S. Leidner, S Shu, Gregory E. Plautz, Zipei Feng and Leaf Huang. Their work appears in journals such as Journal for ImmunoTherapy of Cancer, The Journal of Immunology, Journal of Clinical Oncology, Journal of Translational Medicine and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact